Menarini Group: all 81 studies

Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• KATALYST-HEME-01: Study of the KAT6 Inhibitor MEN2312 in Heme MalignanciesNot yet recruitingNCT07873827Phase 1/2
• A Non-interventional Study of Participants With BPDCN Treated With ChemotherapyRecruitingNCT07785180
• A Registry-study of ELZONRIS in Participants With BPDCNRecruitingNCT07785154
• A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast CancerRecruitingNCT07766018Phase 2
• Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 DaysRecruitingNCT07614958Phase 3
• Cell-based Non-invasive Prenatal Test WorkflowNot yet recruitingNCT07566780
• A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian CancerRecruitingNCT07226427Phase 1
• A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:RecruitingNCT07201584Phase 1
• A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting ConditionsRecruitingNCT07156916Phase 1
• Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)RecruitingNCT06938516
• A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer PatientsRecruitingNCT06833853
• A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract InfectionsRecruitingNCT06828848Phase 2
• A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerRecruitingNCT06638307Phase 1
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruitingNCT06492616Phase 3
• Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerRecruitingNCT05386108Phase 1/2
• Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtientsCompletedNCT06104423Phase 4Results posted
• Effectiveness and Safety of Combination of Nebivolol and Amlodipine in Hypertensive Patients Versus Each MonotherapyCompletedNCT05513937Phase 4Results posted
• Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid TumorsTerminatedNCT05382936Phase 1Results posted
• Effectiveness and Safety of Combination of Amlodipine and Zofenopril in Hypertensive Patients Versus Each MonotherapyCompletedNCT05279807Phase 4Results posted
• Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each MonotherapyCompletedNCT05257148Phase 4Results posted
• Study Evaluating Dexketoprofen Trometamol/Tramadol Hydrochloride Analgesic Efficacy in Acute Low Back PainCompletedNCT05170841Phase 4Results posted
• MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)CompletedNCT04495621Phase 1/2Results posted
• Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site InfectionsTerminatedNCT04042077Phase 3Results posted
• Effect of an Antioxidants Mix on Cognitive Performance and Well Being: The Bacopa, Licopene, Astaxantina, Vitamin B12CompletedNCT03825042Not applicableResults posted
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerCompletedNCT03778931Phase 3Results posted
• MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast CancerCompletedNCT03767335Phase 1Results posted
• Effect of a Treatment With a Nutraceutical Combination on Sub-optimal LDL Cholesterol LevelsCompletedNCT03739242Not applicableResults posted
• Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and AdultsTerminatedNCT03605212Phase 1/2Results posted
• MEN1309 I.v. Infusion in Pts With CD205-positive Metastatic Solid Tumors and Relapsed or Refractory NHL Ph I StudyTerminatedNCT03403725Phase 1Results posted
• MEN1703 (SEL24) in Participants With Acute Myeloid LeukemiaCompletedNCT03008187Phase 1/2Results posted
• Tramadol Hydrochloride and Dexketoprofen Trometamol for the Oral Treatment of Moderate to Severe Acute Pain Following Removal of Impacted Lower Third MolarCompletedNCT02777970Phase 4Results posted
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and AsthmaCompletedNCT02761252Phase 4Results posted
• SL-401 in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed and Refractory Multiple MyelomaTerminatedNCT02661022Phase 1/2Results posted
• Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or UrticariaCompletedNCT02576041Phase 4Results posted
• Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With GoutCompletedNCT02500641Phase 4Results posted
• Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid LeukemiaTerminatedNCT02353143Phase 1Results posted
• SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete RemissionTerminatedNCT02270463Phase 1/2Results posted
• Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF)CompletedNCT02268253Phase 1/2Results posted
• Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet FormulationsCompletedNCT02209454Phase 1Results posted
• Fasitibant Intra-articular Injection in Patients With Symptomatic Osteoarthritis of the KneeCompletedNCT02205814Phase 2Results posted
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)TerminatedNCT02120027Phase 3Results posted
• Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid LeukemiaCompletedNCT02113982Phase 1/2Results posted
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedNCT02107196Phase 3Results posted
• Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeCompletedNCT02078648Phase 1/2Results posted
• Oral Treatment for Gynaecological Post-operative Pain With Dexketoprofen Trometamol and Tramadol HydrochlorideCompletedNCT01904149Phase 3Results posted
• Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol HydrochlorideCompletedNCT01902134Phase 3Results posted
• Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic MalignanciesCompletedNCT01724528Phase 3Results posted
• Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversionCompletedNCT01534962Phase 2Results posted
• Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding IntoleranceCompletedNCT01532518Phase 2Results posted
• Analgesic Effect of Different Combinations of Dexketoprofen Trometamol With Tramadol Hydrochloride in a Model of Moderate to Severe PainCompletedNCT01307020Phase 2Results posted
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)CompletedNCT01303224Phase 2Results posted
• Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant ColicCompletedNCT01258153Phase 2Results posted
• A Locally Injected Bradykinin Antagonist for TReatment of OSteoarthritiSCompletedNCT01091116Phase 2Results posted
• Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)CompletedNCT00761007Phase 2Results posted
• A Phase I Study to Evaluate the Oral Absorption of Nepadutant in InfantsCompletedNCT00655083Phase 1Results posted
• Olmesartan/HCTZ 40/12.5 mg Combination Therapy Versus Olmesartan Medoxomil 40 mg Monotherapy in Essential HypertensionCompletedNCT00441350Phase 3Results posted
• Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer PatientsTerminatedNCT00418574Phase 2/3Results posted
• A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady StateActive, not recruitingNCT07146711Phase 1
• A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed ConditionsActive, not recruitingNCT07091669Phase 1
• A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral SuspensionCompletedNCT07036861Phase 1
• Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose AdministrationCompletedNCT06547242Phase 1
• A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive ChemotherapyActive, not recruitingNCT06456463Phase 2
• A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic FunctionCompletedNCT06126575Phase 1
• Fetal Cell Analysis From Maternal BloodStatus unknownNCT05671744Not applicable
• ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)Active, not recruitingNCT05662345
• ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer StudyActive, not recruitingNCT05596409Phase 2
• Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerActive, not recruitingNCT05563220Phase 1/2
• Observational Study of Efficacy, Safety and Tolerability of Fentanyl in Korean Cancer PatientsCompletedNCT03895762
• Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential HypertensionCompletedNCT03847350
• Different Level of Single-dose and Multiple-dose Bilastine PK Study in Chinese PopulationStatus unknownNCT03633760Phase 1
• Phase 1, First-in-Human Study of RAD140 in Postmenopausal Women With Breast CancerCompletedNCT03088527Phase 1
• A Study of Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male SubjectsStatus unknownNCT02817932Phase 1
• A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid TumorsCompletedNCT02667873Phase 1
• Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast CancerCompletedNCT02650817Phase 1
• A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast CancerCompletedNCT02338349Phase 1
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)WithdrawnNCT02320318Phase 3
• Efficacy and Safety Study of Kinerase® for Treatment of Cutaneous Facial PhotodamageCompletedNCT01885091Phase 4
• Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVTCompletedNCT01880216Phase 3
• Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional TreatmentWithdrawnNCT01309009Phase 2
• Effects of Nebivolol Versus Metoprolol Succinate on Endothelial FunctionCompletedNCT01248338Phase 4
• Effects of Nebivolol on Subclinical Left Ventricular dySfunction: A Comparative Study Against MetoprololCompletedNCT00942487Phase 3

← Menarini Group overview and focus areas